TrialJAMA oncology2024

Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.

Michael Cecchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.